Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Siguret, V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 19 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pautas, E; Siguret, V; d'Urso, M; Laurent, M; Gaussem, P; Fevrier, M; Durand-Gasselin, B
      Monitoring of tinzaparin treatment at treatment dose of 10 days in elderlypatients

      REVUE DE MEDECINE INTERNE
    2. Siguret, V; Pautas, E; Fevrier, M; Wipff, C; Durand-Gasselin, B; Laurent, M; Andreux, JP; d'Urso, M; Gaussem, P
      Elderly patients treated with tinzaparin (Innohep (R)) administered once daily (175 anti-Xa IU/kg): Anti-Xa and anti-IIa activities over 10 days

      THROMBOSIS AND HAEMOSTASIS
    3. Pautas, E; Gaillard, M; Chambon-Pautas, C; Siguret, V; Andreux, JP; Gaussem, P
      Myelodysplastic syndromes: diagnosis and care in elderly patients over 70

      PRESSE MEDICALE
    4. Le Blanche, AF; Siguret, V; Settegrana, C; Bohus, S; de Chermont, EL; Andreux, JP; Gaussem, P
      Ruling out acute deep vein thrombosis by ELISA plasma D-dimer assay versusultrasound in inpatients more than 70 years old

      ANGIOLOGY
    5. SIGURET V; JAULT T; DREYFUS M; GALLAIS Y; ANDREUX JP; PATHIER D; GAUSSEM P
      FACTOR-VII QUALITATIVE DEFICIENCY AND PREGNANCY

      Thrombosis and haemostasis
    6. Andre, E; Siguret, V; Alhenc-Gelas, M; Saint-Jean, O; Gaussem, P
      Venous thrombosis in older people: Prevalence of the factor V gene mutation Q506

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    7. GAUSSEM P; LEBLANCHE AF; PELLEGRIN B; ANDREUX JP; SIGURET V
      USEFULNESS OF PLASMA D-DIMERS FOR THE DIAGNOSIS OF VENOUS THROMBOEMBOLISM IN ELDERLY

      Thrombosis and haemostasis
    8. ANDRE E; ALHENCEGELAS M; SIGURET V; GAUSSEM P
      VENOUS THROMBOSIS IN ELDERLY - PREVALENCE OF FACTOR-V GENE MUTATION Q506

      Thrombosis and haemostasis
    9. SIGURET V; VERNY M; SIFER L; STEPANIAN A; SAINTJEAN O; ANDREUX JP; GAUSSEM P
      PREDICTIVE DAILY MAINTENANCE DOSE OF WARFARIN IN ELDERLY PATIENTS

      Thrombosis and haemostasis
    10. SIGURET V; ALHENCGELAS M; AIACH M; FIESSINGER JN; GAUSSEM P
      RESPONSE TO DDAVP-STIMULATION IN 13 PATIENTS WITH BUERGERS-DISEASE

      Thrombosis research
    11. LEBLANCHE AF; SETTEGRANA C; SIGURET V; PELLEGRIN B; ANDREUX J; LEMASNE E
      ULTRASOUND AND PLASMA ELISA D-DIMER IN GERIATRIC INPATIENTS - AN EFFECTIVE COMBINATION TO EXCLUDE ACUTE DEEP-VEIN THROMBOSIS OF THE LOWER-LIMBS

      Radiology
    12. SIGURET V; RIBBA AS; CHRISTOPHE O; CHERET G; OBERT B; ROUAULT C; NISHIKUBO T; MEYER D; GIRMA JP; PIETU G
      CHARACTERIZATION OF RECOMBINANT VON-WILLEBRAND-FACTORS MUTATED ON CYSTEINE-509 OR CYSTEINE-509695

      Thrombosis and haemostasis
    13. RIBBA AS; SIGURET V; CHEREL G; CHRISTOPHE O; OBERT B; NISHIKUBO T; GIRMA JP; PIETU G; MEYER D
      CYSTEINE-509 AND CYSTEINE-695 OF VON-WILLEBRAND-FACTOR PLAY A DISTINCT ROLE IN THE BINDING TO PLATELET GLYCOPROTEIN-IB

      Thrombosis and haemostasis
    14. SIGURET V; RIBBA AS; CHEREL G; MEYER D; PIETU G
      EFFECT OF PLASMID SIZE AN TRANSFORMATION EFFICIENCY BY ELECTROPORATION OF ESCHERICHIA-COLI DH5-ALPHA

      BioTechniques
    15. SIGURET V; LAVERGNE J; CHEREL G; BOYERNEUMANN C; RIBBA AS; BAHNAK BR; MEYER D; PIETU G
      A NOVEL CASE OF COMPOUND HETEROZYGOSITY WITH NORMANDY TYPE-I VON-WILLEBRAND DISEASE (VWD) - DIRECT DEMONSTRATION OF THE SEGREGATION OF ONE ALLELE WITH A DEFECTIVE EXPRESSION AT THE MESSENGER-RNA LEVEL CAUSING TYPE-I VWD/

      Human genetics
    16. PIETU G; RIBBA AS; CHEREL G; SIGURET V; OBERT B; ROUAULT C; GINSBURG D; MEYER D
      EPITOPE MAPPING OF INHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN VON-WILLEBRAND-FACTOR BY USING RECOMBINANT CDNA LIBRARIES

      Thrombosis and haemostasis
    17. RIBBA AS; CHRISTOPHE O; DERLON A; CHEREL G; SIGURET V; LAVERGNE JM; GIRMA JP; MEYER D; PIETU G
      DISCREPANCY BETWEEN IIA-PHENOTYPE AND IIB-GENOTYPE IN A PATIENT WITH A VARIANT OF VON-WILLEBRAND DISEASE

      Blood
    18. LAVERGNE JM; PIAO Y; RIBBA AS; GIRMA JP; SIGURET V; PIETU G; BOYERNEUMANN C; SCHANDELONG A; BAHNAK BR; MEYER D
      FUNCTIONAL-ANALYSIS OF THE ARG91GLN SUBSTITUTION IN THE FACTOR-VIII BINDING DOMAIN OF VON-WILLEBRAND-FACTOR DEMONSTRATES VARIABLE PHENOTYPIC-EXPRESSION

      Thrombosis and haemostasis
    19. SIGURET V; RIBBA AS; CHRISTOPHE O; GIRMA JP; CHEREL G; MEYER D; PIETU G
      RECOMBINANT VON-WILLEBRAND-FACTOR MUTATED ON CYS-695 DEMONSTRATES THECRUCIAL ROLE OF THE AMINO-ACID IN BINDING TO PLATELET GLYCOPROTEIN-IB

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 03:26:48